Investigation of Biobanks
Biobanks: What More Do We Need To Know?
The investigation aims to illuminate, from a research perspective, the development potential and opportunities for the biobanks in neglected diseases.
The investigation is not intended to propose solutions, but to address the needs and potential problems. The investigator will assure that representatives of all relevant higher education institutions, agencies and research fields are given the opportunity to submit their viewpoints. The findings of this assignment should be made available as a report no later than May 30, 2012.
While you may not be using biosamples for your ongoing research, your feedback about biorepositories is very important to us. Please take a minute for this survey here (a new browser window will open). To enter the survey site manually, please copy this http://www.surveymonkey.com/s/S23GDW7 into your browser address line.
All answers to this simple questionnaire are anonymous. Your name or other identifying information is not being collected. We would appreciate your response by May 15, 2012. If you have any questions, please call toll-free at +1-855-966-3555.
Download survey in pdf
I support the petition to designate June 25 as Vitiligo World Day and save millions of people worldwide from social isolation and persecution.
What is coming?
May 24, 2013: VRF Presentation at EADV Spring Symposium
Sodium oxodihydroacridinylacetate in treatment of active vitiligo. Results of preliminary clinical study. Abstract and presentation here
Is it possible to stop the progression of vitiligo?
Vitiligo is progressive in 73% of cases and regressive in 1.3%. We usually explain to the patients that progression depends on the modality of the disease spreading: l...
I have vitiligo: will my children have vitiligo too?
Although most cases of vitiligo are sporadic, familial clustering is not uncommon, and up to 20% of patients report on the affected relatives. In whites, the lifetime ...
How can I treat vitiligo?
Choosing a treatment for vitiligo can be difficult, sometimes overwhelming. In general, first-line therapy should be safe, effective, minimally invasive, and cost effi...
What causes vitiligo?
It remains unclear what causes damage to melanocytes and their subsequent total inactivation and/or disappearance in vitiligo skin. There are several theories; the mos...